AU Stock MarketDetailed Quotes
ACWOC Actinogen Medical Ltd
- 0.008
- 0.0000.00%
20min DelayTrading Dec 2 12:00 AET
0Market Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.008Pre Close0.00Turnover0.01052wk High0.00%Turnover Ratio0Shares0.00552wk Low--EPS TTM0Float Cap0.010Historical High0.00P/E (Static)0Shs Float0.005Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Actinogen Medical Ltd Company
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Company Profile
SymbolACWOC
Company NameActinogen Medical Ltd
Founded1999
MarketASX
Fiscal Year Ends06-30
Address109 Pitt Street Level 9, Suite 901
CitySydney
CountryAustralia
Zip Code2000
Phone+61 289647401
Websitehttps://www.actinogen.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Steven Gourlay
- Executive Director, Chief Executive Officer and Managing Director
- --
- Jeff Carter
- Chief Financial Officer
- --
- Dana Hilt
- Chief Medical Officer
- --
- Tamara Miller
- Senior Vice President - Product Development
- --
- Geoffrey E.D Brooke
- Non-Executive Chairman of the Board
- --
- Malcolm John McComas
- Non-Executive Director
- --
- George Morstyn
- Non-Executive Director
- --
- Nicki Vasquez
- Non-Executive Director
- --
- Peter Webse
- Company Secretary
- --
- Fujun Li
- Head of Manufacturing
- --
- Michael Roberts
- Investor Relations
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data